Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
about
NF-κB in inflammation and renal diseasesDoes antigen masking by ubiquitin chains protect from the development of autoimmune diseases?Roles of the NF-kappaB pathway in lymphocyte development and function.Truncation of the deubiquitinating domain of CYLD in myelomonocytic cells attenuates inflammatory responses.SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination.Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-κB.MicroRNA transcriptomes of distinct human NK cell populations identify miR-362-5p as an essential regulator of NK cell functionCYLD-mediated signaling and diseases.Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signalingDeubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signalingA new look at T cell receptor signaling to nuclear factor-κBTruncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturationDeubiquitylation and regulation of the immune response.CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections.Deubiquitinases in the regulation of NF-κB signaling.Emerging role of ubiquitination in antiviral RIG-I signalingRegulation of NF-κB by deubiquitinases.NF-κB function in B lymphocytes.Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.Immune diseases caused by mutations in kinases and components of the ubiquitin system.Signaling mechanisms regulating B-lymphocyte activation and tolerance.Roles of the NF-κB Pathway in B-Lymphocyte Biology.CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome.Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.Clinical significance of down-regulated cylindromatosis gene in chronic lymphocytic leukemia.New insights into NF-kappaB regulation and function.Immune Regulation by Ubiquitin Tagging as Checkpoint Code.Nuclear Factor-kappaB in Autoimmunity: Man and Mouse.Functional nature of a novel mutant CYLD observed in pediatric lymphoblastic B-cell leukemia.
P2860
Q27021276-68A860A0-F9EF-4A0A-B28D-DC9A067BE640Q28387136-E3F7FCB4-C93D-4910-92B8-8B759C63F442Q33800318-60002E16-9570-4F81-9389-3FF285B0FF22Q33809154-5B5B426B-3E6F-43D9-896B-3F1BC16B6869Q34100910-890AE254-B700-49DB-B774-4F0C50D85AC6Q34111461-3A467ACA-4F6C-4D8C-8AAA-D99CDB176A8FQ34828781-9C05C06C-F004-4133-95A3-958D366EFF13Q35535497-AF80DEFD-F94D-4236-A553-105FACB52CF2Q35565726-1A19AF30-F0CA-4875-B5F1-DE9966AA4972Q35625506-8F740B5B-7D1D-4BC5-A798-B6BD1ECF53F3Q36512214-9C351CDB-ECA8-46AD-A5FC-5773D184CB75Q36585593-CF8949CB-281B-4CD0-B173-5437D3444C53Q36906449-174E25AC-0B12-4150-B50A-BBBC7C605BECQ37165388-C5A252CD-4C1D-42F1-BA0E-E86EE7E0F04CQ37184075-CFB0052D-8DF7-4AA7-9DA6-E90AE5BEA488Q37448141-26C17A32-291D-41ED-9974-4C10E2B9554EQ37728927-0005DBC2-BC54-4648-B580-4BADA6B3E4FEQ37814068-98F705A4-AE9F-4FE6-A409-488481E164C7Q37990630-DFE78ADE-3B8A-4A82-AF0A-8FFD411E4F15Q37995682-E4328B80-404A-4346-B86A-A530B40F7352Q37995689-3351BC86-98DE-4705-A20E-2583B605744AQ38021448-8D1D5BDD-88C0-4F23-8CD2-A8A14D8F9A0CQ38212818-D1B940DF-1441-416B-9CED-B12EC05B0E6FQ38334794-11DD4BB7-EAC2-4E15-84B8-6FFE5D67C354Q38567094-B3526AEC-8F5A-4D37-AD22-3A10B1C67506Q39210955-B36022C5-B926-4EB5-A3EF-B85BFE83BB97Q39432317-2AA6139E-7EF4-4A75-A443-E6265C4DB5ACQ43877768-A738B275-DB29-4B00-8186-7D5E8EF92E73Q43892008-96EF35C9-132C-4560-9BAF-EF80CFF58D08Q46030980-154F4294-6C3B-4413-97B4-892E25042FFCQ47097632-EE03DE70-399F-4E86-B7F9-E411A32B2710Q47774246-B766B0AF-F0BD-4FB4-A13B-B28D21906BCFQ52311688-18583A22-2F10-4C34-A9B3-23E171D585ECQ52970760-38744044-981A-4F43-9736-FEBF8241D80A
P2860
Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.
@en
Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.
@nl
type
label
Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.
@en
Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.
@nl
prefLabel
Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.
@en
Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.
@nl
P2093
P2860
P356
P1476
Deubiquitinating enzyme CYLD r ...... notype maintenance of B cells.
@en
P2093
Andrew J Lee
Ato Wright
Minying Zhang
Shao-Cong Sun
William R Reiley
Xuefeng Wu
P2860
P304
15884-15893
P356
10.1074/JBC.M609952200
P407
P577
2007-03-27T00:00:00Z